Search - tctmd.com

Displaying 141 - 160 of 275

Sort: Relevancy | Date

Presentation TCT 2017

PLLA-Based Biolimus A9 Elution II: From Nobori to Ultimaster Specifications and Results

Presenter: Ioannis Iakovou, Gert Richardt, Shigeru Saito

October 30, 2017

Presentation TCT 2017

PLLA-Based Biolimus A9 Elution I: Outcomes With the BioMatrix Family of DES

Presenter: Ioannis Iakovou, Gert Richardt, Christophe Dubois

October 30, 2017

Presentation TCT 2017

The Orsiro Sirolimus-eluting Stent: Outcomes From the BIOFLOW and BIORESORT Trials

Presenter: Ioannis Iakovou, Gert Richardt, Clemens von Birgelen

October 30, 2017

Presentation TCT 2017

MiStent and DESSOLVE III Outcomes: Are the Stent and Clinical Trial Results Unique?

Presenter: Ioannis Iakovou, Gert Richardt, Robert J. de Winter

October 30, 2017

Presentation TCT 2017

Case Resolution: A High-Risk Patient With Complex Mutlivessel Disease How We Treated

Presenter: Issam D. Moussa, Emmanouil S. Brilakis

October 30, 2017

Presentation TCT 2017

Expanding Clinical Evidence With SYNERGY: From EVOLVE II to Real-world Registries and EVOLVE DAPT

Presenter: Ioannis Iakovou, Gert Richardt, Dean J. Kereiakes

October 30, 2017

Presentation TCT 2017

PCI vs CABG in Multivessel Disease: What Do the US Guidelines and AUC Say?

Presenter: Issam D. Moussa, Manesh R. Patel

October 30, 2017

Presentation TCT 2017

Pros and Cons of Bioabsorbable Polymer-Based DES: Will They Translate Into Improved Clinical Outcomes Compared to the Best Durable Polymer-Based DES?

Presenter: Ioannis Iakovou, Gert Richardt, Renu Virmani

October 30, 2017

Presentation TCT 2017

PCI vs CABG in Multivessel Disease: What Do the Data and EU Guidelines Say?

Presenter: Issam D. Moussa, Alfredo R. Galassi

October 30, 2017

Presentation TCT 2017

Case Presentation: A High-Risk Patient With Complex Multivessel Disease PCI vs CABG?

Presenter: Issam D. Moussa, Emmanouil S. Brilakis

October 30, 2017

Presentation TCT 2017

BioNIR: Specifications and BIONICS/NIREUS Results in Perspective

Presenter: Stephen G. Ellis, David E. Kandzari

October 30, 2017

Presentation TCT 2017

Resolute and Onyx Zotarolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective

Presenter: Stephen G. Ellis, David E. Kandzari, Matthew J. Price

October 30, 2017

Presentation TCT 2017

Case Resolution: A Patient With Stable Angina Our Approach and Outcome

Presenter: Sripal Bangalore, Manesh R. Patel, Adhir Shroff

October 30, 2017

Presentation TCT 2017

Are There Meaningful Differences Between Current Durable Polymer-Based vs Bioabsorbable Polymer-Based vs Polymer-Free Metallic DES? Pathologic Insights

Presenter: Giulio G. Stefanini, Stephan Windecker, Renu Virmani

October 30, 2017

Presentation TCT 2017

Promus Element Everolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective

Presenter: Stephen G. Ellis, David E. Kandzari, Sigmund Silber

October 30, 2017

Presentation TCT 2017

Revascularization in Stable Ischemic Heart Disease: What Do the US Guidelines and AUC Say?

Presenter: Sripal Bangalore, Manesh R. Patel, David J. Maron

October 30, 2017

Presentation TCT 2017

XIENCE Everolimus-Eluting Stents: Device Iterations, Randomized/Registry Outcomes Data in Perspective and the Move to Shorter DAPT

Presenter: Stephen G. Ellis, David E. Kandzari, Tullio Palmerini

October 30, 2017

Presentation TCT 2017

Revascularization in Stable Ischemic Heart Disease: What Do the Data and EU Guidelines Say?

Presenter: Sripal Bangalore, Manesh R. Patel, Carlo Di Mario

October 30, 2017

Presentation TCT 2017

Case Introduction: A Patient With Stable Angina How Should We Evaluate and Treat?

Presenter: Sripal Bangalore, Manesh R. Patel, Adhir Shroff

October 30, 2017

Presentation TCT 2017

Bifurcation Stents 1: TRYTON Description, Data, and Case Examples

Presenter: Alaide Chieffo, Jeffrey W. Moses, Philippe Genereux

October 30, 2017

Advertisement

PLLA-Based Biolimus A9 Elution II: From Nobori to Ultimaster Specifications and Results

PLLA-Based Biolimus A9 Elution I: Outcomes With the BioMatrix Family of DES

The Orsiro Sirolimus-eluting Stent: Outcomes From the BIOFLOW and BIORESORT Trials

MiStent and DESSOLVE III Outcomes: Are the Stent and Clinical Trial Results Unique?

Case Resolution: A High-Risk Patient With Complex Mutlivessel Disease How We Treated

Expanding Clinical Evidence With SYNERGY: From EVOLVE II to Real-world Registries and EVOLVE DAPT

PCI vs CABG in Multivessel Disease: What Do the US Guidelines and AUC Say?

Pros and Cons of Bioabsorbable Polymer-Based DES: Will They Translate Into Improved Clinical Outcomes Compared to the Best Durable Polymer-Based DES?

PCI vs CABG in Multivessel Disease: What Do the Data and EU Guidelines Say?

Case Presentation: A High-Risk Patient With Complex Multivessel Disease PCI vs CABG?

BioNIR: Specifications and BIONICS/NIREUS Results in Perspective

Resolute and Onyx Zotarolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective

Case Resolution: A Patient With Stable Angina Our Approach and Outcome

Are There Meaningful Differences Between Current Durable Polymer-Based vs Bioabsorbable Polymer-Based vs Polymer-Free Metallic DES? Pathologic Insights

Promus Element Everolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective

Revascularization in Stable Ischemic Heart Disease: What Do the US Guidelines and AUC Say?

XIENCE Everolimus-Eluting Stents: Device Iterations, Randomized/Registry Outcomes Data in Perspective and the Move to Shorter DAPT

Revascularization in Stable Ischemic Heart Disease: What Do the Data and EU Guidelines Say?

Case Introduction: A Patient With Stable Angina How Should We Evaluate and Treat?

Bifurcation Stents 1: TRYTON Description, Data, and Case Examples

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content